Structure Therapeutics American Stock Technical Analysis
| GPCR Stock | 19.77 0.17 0.85% |
As of the 30th of March, Structure Therapeutics has the Variance of 21.4, coefficient of variation of (1,117), and Risk Adjusted Performance of (0.07). Structure Therapeutics technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Structure Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Structure Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 19.77 per share. Given that Structure Therapeutics has information ratio of (0.08), we advise you to double-check Structure Therapeutics American's current market performance to make sure the company can sustain itself at a future point.
Structure Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Structure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StructureStructure |
Structure Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 83.0 | Strong Buy | 13 | Odds |
Most Structure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Structure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Structure Therapeutics, talking to its executives and customers, or listening to Structure conference calls.
Structure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Structure Therapeutics Technical Analysis
The output start index for this execution was seven with a total number of output elements of fifty-four. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Structure Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Structure Therapeutics Trend Analysis
Use this graph to draw trend lines for Structure Therapeutics American. You can use it to identify possible trend reversals for Structure Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Structure Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Structure Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Structure Therapeutics American applied against its price change over selected period. The best fit line has a slop of 0.16 , which may suggest that Structure Therapeutics American market price will keep on failing further. It has 122 observation points and a regression sum of squares at 929.46, which is the sum of squared deviations for the predicted Structure Therapeutics price change compared to its average price change.About Structure Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Structure Therapeutics American on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Structure Therapeutics American based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Structure Therapeutics price pattern first instead of the macroeconomic environment surrounding Structure Therapeutics. By analyzing Structure Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Structure Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Structure Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 7.16 | 19.14 | 24.74 | 25.98 | Net Debt To EBITDA | 1.73 | 1.21 | 1.05 | 0.64 |
Structure Therapeutics March 30, 2025 Technical Indicators
Most technical analysis of Structure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Structure from various momentum indicators to cycle indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 3.36 | |||
| Coefficient Of Variation | (1,117) | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.4 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 25.66 | |||
| Value At Risk | (8.73) | |||
| Potential Upside | 5.95 | |||
| Skewness | (0.04) | |||
| Kurtosis | 1.41 |
Structure Therapeutics March 30, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Structure stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (0.17) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 19.36 | ||
| Day Typical Price | 19.50 | ||
| Price Action Indicator | 0.32 | ||
| Market Facilitation Index | 0.98 |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.